Anal, penile, and oral high-risk HPV infections and HPV seropositivity in HIV-positive and HIV-negative men who have sex with men

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Van Rijn, Vera M ^a   Mooij, Sofie H ^b,d   Mollers, Madelief ^a   Snijders, Peter J F ^c   Speksnijder, Arjen G C L ^b   King, Audrey J ^a   De Vries, Henry J C ^a,b,d   Van Eeden, Arne ^e,g   Van Der Klis, Fiona R M ^a   De Melker, Hester E ^a   Van Der Sande, Marianne A B ^a,f   Van Der Loeff, Maarten F Schim ^b,d  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b DEPARTMENT OF INFECTIOUS DISEASES   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e Jan Van Goyen Medical Center   (Netherlands)

^f UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^g DC Klinieken Oud Zuid ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY; VIRUS DNA;

ADULT; AGE DISTRIBUTION; ANALYTIC METHOD; ANTIBODY BLOOD LEVEL; ANUS DISEASE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DNA DETERMINATION; GENOTYPE; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 58; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; MEN WHO HAVE SEX WITH MEN; MOUTH INFECTION; NETHERLANDS; PAPILLOMAVIRUS INFECTION; PENIS DISEASE; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; REVERSE LINE BLOT ASSAY; VIRUS LIKE AGENT; ANAL CANAL; COMPLICATION; HIV SEROPOSITIVITY; MALE HOMOSEXUALITY; MIDDLE AGED; MOUTH; MULTIVARIATE ANALYSIS; PAPILLOMAVIRUS INFECTIONS; PENIS; PREVALENCE; RISK FACTOR; SPECIES DIFFERENCE; STATISTICS AND NUMERICAL DATA; VIROLOGY;

ADULT; ANAL CANAL; HIV SEROPOSITIVITY; HOMOSEXUALITY, MALE; HUMANS; MALE; MIDDLE AGED; MOUTH; MULTIVARIATE ANALYSIS; NETHERLANDS; PAPILLOMAVIRUS INFECTIONS; PENIS; PREVALENCE; RISK FACTORS; SPECIES SPECIFICITY;

EID: 84908465296     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0092208     Document Type: Article

References (39)

1. Baseman JG, Koutsky LA (2005) The epidemiology of human papillomavirus infections. J Clin Virol 32: 16-24.
2. Giuliano AR, Tortolero-Luna G, Ferrer E, Burchell AN, de Sanjosé S, et al. (2008) Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions. Vaccine 26: 17-28.
3. Nyitray AG, Carvalho da Silva RJ, Baggio ML, Lu B, Smith D, et al. (2011) Age-specific prevalence of and risk factors for anal human papillomavirus (HPV) among men who have sex with women and men who have sex with men: The HPV in men (HIM) study. J Infect Dis 203: 49-57.
4. Smith JS, Gilbert PA, Melendy A, Rana RK, Pimenta JM (2011) Age-specific prevalence of human papillomavirus infection in males: A global review. J Adolesc Health 48: 540-552.
5. Mooij SH, Boot HJ, Speksnijder AG, Stolte IG, Meijer CJ, et al. (2013) Oral human papillomavirus infection in HIV-negative and HIV-infected MSM. AIDS 27: 2117-2128.
6. Van Aar F, Mooij SH, van der Sande MA, Speksnijder AG, Stolte IG et al. (2013) Anal and penile high-risk human papillomavirus prevalence in HIVnegative and HIV-infected MSM. AIDS 27: 2921-2931.
7. Hu Y, Qian HZ, Sun J, Gao L, Yin L, et al. (2013) Anal human papillomavirus infection among HIV-infected and uninfected men who have sex with men in Beijing, China. J Acquir Immune Defic Syndr 64: 103-114.
8. Machalek DA, Poynten M, Jin F, Fairley CK, Farnsworth A, et al. (2012) Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: A systematic review and meta-analysis. Lancet Oncol 13: 487-500.
9. Phanuphak N, Teeratakulpisarn N, Pankam T, Kerr SJ, Barisri J, et al. (2013) Anal human papillomavirus infection among Thai men who have sex with men with and without HIV infection: Prevalence, incidence, and persistence. J Acquir Immune Defic Syndr 63: 472-479.
10. Sirera G, Videla S, Pinol M, Cañadas MP, Llatjos M, et al. (2006) High prevalence of human papillomavirus infection in the anus, penis and mouth in HIV-positive men. AIDS 20: 1201-1204.
11. Giuliano AR, Lee JH, Fulp W, Villa LL, Lazcano E, et al. (2011) Incidence and clearance of genital human papillomavirus infection in men (HIM): A cohort study. Lancet 377: 932-940.
12. Trottier H, Franco EL (2006) The epidemiology of genital human papillomavirus infection. Vaccine 24: 1-15.
13. Carter JJ, Koutsky LA, Hughes JP, Lee SK, Kuypers J, et al. (2000) Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection. J Infect Dis 181: 1911-1919.
14. Edelstein ZR, Carter JJ, Garg R, Winer RL, Feng Q, et al. (2011) Serum antibody response following genital (alpha)9 human papillomavirus infection in young men. J Infect Dis 204: 209-216.
15. af Geijersstam V, Kibur M, Wang Z, Koskela P, Pukkala E, et al. (1998) Stability over time of serum antibody levels to human papillomavirus type 16. J Infect Dis 177: 1710-1714.
16. Carter JJ, Koutsky LA, Wipf GC, Christensen ND, Lee SK, et al. (1996)The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women. J Infect Dis 174: 927-936.
17. de Gruijl TD, Bontkes HJ, Walboomers JM, Coursaget P, Stukart MJ, et al. (1999) Immune responses against human papillomavirus (HPV) type 16 viruslike particles in a cohort study of women with cervical intraepithelial neoplasia. I. Differential T-helper and IgG responses in relation to HPV infection and disease outcome. J Gen Virol 80: 399-408.
18. Ho GY, Studentsov YY, Bierman R, Burk RD (2004) Natural history of human papillomavirus type 16 virus-like particle antibodies in young women. Cancer Epidemiol Biomarks 13: 110-116.
19. Wideroff L, Schiffman MH, Nonnenmacher B, Hubbert N, Kirnbauer R, et al. (1995) Evaluation of seroreactivity to human papillomavirus type 16 virus-like particles in an incident case-control study of cervical neoplasia. J Infect Dis 172: 1425-1430.
20. Vriend HJ, Bogaards JA, van der Klis FR, Scherpenisse M, Boot HJ, et al. (2013) Patterns of human papillomavirus DNA and antibody positivity in young males and females, suggesting a site-specific natural course of infection. PloS one 8: E60696.
21. Lu B, Viscidi RP, Wu Y, Nyitray AG, Villa LL, et al. (2012) Seroprevalence of human papillomavirus (HPV) type 6 and 16 vary by anatomic site of HPV infection in men. Cancer Epidemiol Biomarks 21: 1542-1546.
22. Heiligenberg M, Alberts CJ, Waterboer T, Speksnijder AG, de Vries HJ, et al. (2013) Route of sexual exposure is independently associated with seropositivity to HPV-16 and HPV-18 among clients of an STI clinic in the Netherlands. J Infect Dis 208: 1081-1085.
23. Poynten IM, Jin F, Templeton DJ, Prestage GP, Donovan B, et al. (2012) Prevalence, incidence, and risk factors for human papillomavirus 16 seropositivity in Australian homosexual men. Sex Transm Dis 39: 726-732.
24. Jansen IA, Geskus RB, Davidovich U, Jurriaans S, Coutinho RA, et al. (2011) Ongoing HIV-1 transmission among men who have sex with men in Amsterdam: A 25-year prospective cohort study. AIDS 25: 493-501.
25. Kleter B, van Doorn LJ, ter Schegget J, Schrauwen L, van Krimpen K, et al. (1998) Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am J Pathol 153: 1731-1739.
26. Scherpenisse M, Mollers M, Schepp RM, Boot HJ, de Melker HE, et al. (2012) Seroprevalence of seven high-risk HPV types in the Netherlands. Vaccine 30: 6686-6693.
27. Frey A, Di CJ, Zurakowski D (1998) A statistically defined endpoint titer determination method for immunoassays. J Immunol Methods 221: 35-41.
28. Hagensee ME, Kiviat N, Critchlow CW, Hawes SE, Kuypers J, et al. (1997) Seroprevalence of human papillomavirus types 6 and 16 capsid antibodies in homosexual men. J Infect Dis 176: 625-631.
29. Kreimer AR, Alberg AJ, Daniel R, Gravitt PE, Viscidi R, et al. (2004) Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus. J Infect Dis 189: 686-698.
30. Silverberg MJ, Schneider MF, Silver B, Anastos KM, Burk RD, et al. (2006) Serological detection of human papillomavirus type 16 infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women. Clin Vaccine Immunol 13: 511-519.
31. Mooij SH, van der Klis FR, van der Sande MA, Stolte IG, Meijer CJ, et al. (2013) Seroepidemiology of high-risk human papillomavirus (HPV) in HIVnegative and HIV-infected men who have sex with men (MSM): The HIV & HPV in MSM (H2M) study. Cancer Epidemiol Biomarks 22: 1698-1708.
32. Xue X, Gange SJ, Zhong Y, Burk RD, Minkoff H, et al. (2010) Marginal and mixed-effects models in the analysis of human papillomavirus natural history data. Cancer Epidemiol Biomarks 19: 159-169.
33. Slavinsky J, Kissinger P, Burger L, Boley A, DiCarlo RP, et al. (2001) Seroepidemiology of low and high oncogenic risk types of human papillomavirus in a predominantly male cohort of STD clinic patients. Int J STD AIDS 12: 516-523.
34. Svare EI, Kjaer SK, Nonnenmacher B, Worm AM, Moi H, et al. (1997) Seroreactivity to human papillomavirus type 16 virus-like particles is lower in high-risk men than in high-risk women. J Infect Dis 176: 876-883.
35. Paaso AE, Louvanto K, Syrjanen KJ, Waterboer T, Grenman SE et al. (2011) Lack of type-specific concordance between human papillomavirus (HPV) serology and HPV DNA detection in the uterine cervix and oral mucosa. J Gen Virol 92: 2034-2046.
36. Kreimer AR, Alberg AJ, Viscidi R, Gillison ML (2004) Gender differences in sexual biomarkers and behaviors associated with human papillomavirus-16, -18, and -33 seroprevalence. Sex Transm Dis 31: 247-256.
37. Johnson LG, Madeleine MM, Newcomer LM, Schwartz SM, Daling JR (2004) Anal cancer incidence and survival: The surveillance, epidemiology, and end results experience, 1973-2000. Cancer 101: 281-288.
38. Shiels MS, Pfeiffer RM, Gail MH, Hall HI, Li J et al. (2011) Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst 103: 753-762.
39. Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W et al. (2011) Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 29: 4294-4301.